{"id":114,"date":"2026-07-14T17:19:06","date_gmt":"2026-07-14T17:19:06","guid":{"rendered":"https:\/\/dentaltransitions.sites.aigrowthagent.co\/dental-practice-broker-reviews\/"},"modified":"2026-07-14T17:19:06","modified_gmt":"2026-07-14T17:19:06","slug":"dental-practice-broker-reviews","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/dental-practice-broker-reviews\/","title":{"rendered":"Dental Practice Broker Reviews: How to Judge Before You Sign"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li>\n<p>Premier dental practice buyers negotiate deals every week. The choice of sell-side representation can be one of the largest factors in final proceeds.<\/p>\n<\/li>\n<li>\n<p>McLerran &amp; Associates reports an 85-90% transaction rate, well above the industry norm of 35-40%, through CPA-led EBITDA analysis and a structured, auction-style process.<\/p>\n<\/li>\n<li>\n<p>A competitive multi-buyer process can help practices realize meaningfully higher final values than a sale without professional representation.<\/p>\n<\/li>\n<li>\n<p>Owners can evaluate brokers on six consistent criteria: valuation defensibility, buyer-pool quality, competitive tension, transaction success rate, fee alignment, and post-close legacy protection.<\/p>\n<\/li>\n<li>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Talk with McLerran &amp; Associates<\/a> to learn how a sell-side-only process can support your practice&#8217;s outcome.<\/p>\n<\/li>\n<\/ul>\n<h2>Six Ways to Judge a Dental Broker Before You Sign<\/h2>\n<p>Any broker under consideration can be evaluated on the same six dimensions. Applying them consistently removes emotion from the selection process. It also helps surface advisors most likely to protect and support value.<\/p>\n<p><strong>1. Valuation methodology and defensibility.<\/strong> A valuation only matters if it holds up when a buyer&#8217;s due-diligence team examines it. Brokers who issue inflated or unsupported valuations can cause deals to collapse, leaving sellers disappointed after they&#8217;ve already made major life decisions. Ask any broker how they normalize EBITDA (earnings before interest, taxes, depreciation, and amortization, a common measure of a practice&#8217;s true cash profit), which add-backs they document, and whether their work would survive a quality-of-earnings review by a sophisticated buyer.<\/p>\n<p><strong>2. Buyer-pool size and vetting.<\/strong> The breadth and quality of the buyer pool shapes how much real competition a seller can generate. A broker with ties to only one or two DSOs (dental support organizations, companies that acquire and operate multiple practices) cannot create a true market for a practice. It also matters whether poorly run or undercapitalized buyers get screened out before reaching the seller.<\/p>\n<p><strong>3. Competitive tension and offer volume.<\/strong> <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/marketed-process-premium\">Dental practices sold through a structured multi-buyer process can achieve final values averaging roughly 30% above those sold independently<\/a>, according to data from TUSK Practice Sales, FOCUS Investment Banking, and McLerran &amp; Associates observations from 2024-2026. A real or perceived competing bid tends to hold the valuation number in place and discourages last-minute price cuts.<\/p>\n<p><strong>4. Transaction success rate.<\/strong> Close rates vary widely by representation type. McLerran &amp; Associates reports a transaction rate of 85-90%, compared with an industry norm closer to 35-40%.<\/p>\n<p><strong>5. Fee structure and who pays.<\/strong> Most sell-side brokers in the lower-middle market charge an all-in success fee of the final deal value, paid only when the transaction closes. A broker paid only at closing has an incentive to get deals done, but this structure can still create tension during re-trades (attempts by a buyer to lower the agreed price late in the process). Sell-side-only representation, where the advisor never works for the buyer, removes this conflict at its source.<\/p>\n<p><strong>6. Post-close support and legacy protection.<\/strong> The highest bidder is not always the right buyer. An advisor who weighs both price and fit, by vetting buyer strategy, post-close support models, and cultural alignment, protects the patients, staff, and legacy a seller leaves behind.<\/p>\n<p>These same criteria play out differently across broker types. The table below shows how.<\/p>\n<h2>Comparing Broker Types Side by Side<\/h2>\n<p>The table compares five representation categories on transaction rate and buyer-pool strength. Every figure comes from a cited source. Valuation methodology differs by broker type as well: DIY sales rely on buyer-set numbers with no independent check, generalist and multi-vertical advisors often apply inconsistent EBITDA normalization, and lead-gen firms may inflate figures to win a listing. CPA-led, diligence-grade analysis is designed to hold up under buyer scrutiny.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Broker Type<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Transaction Rate<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Buyer-Pool &amp; Competitive Tension<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>DIY \/ FSBO<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>~15-20%<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Single buyer; no competitive tension<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Local generalist broker<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Below industry norm<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>1-2 DSOs or small local list<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Multi-vertical advisor<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Variable<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Generic buyer pool; limited dental-specific relationships<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>&#8220;Free valuation&#8221; lead-gen firm<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/marketed-process-premium\">~35-40% industry norm<\/a><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Partial buyer list; limited auction structure<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>McLerran &amp; Associates<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p><strong>~85-90%<\/strong><\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Large vetted buyer pool; structured auction generating roughly 10 offers in 45-60 days<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>What Dental Brokers Typically Charge<\/h2>\n<p>Broker fees for dental practice sales are almost always success fees, meaning the broker gets paid only when the transaction closes. Some firms instead use a sliding scale, sometimes called a Double Lehman structure. Under this model, the percentage drops as the sale price rises: for example, 10% on the first $1 million, 8% on the second, 6% on the third, 4% on the fourth, and 2% on anything above $4 million. This structure tends to apply to larger transactions where a flat percentage would produce an unusually large fee.<\/p>\n<p>Larger practices may negotiate rates down to 6-8%. Smaller practices under $300,000 in collections often see fees at the higher end of the range, since marketing and due-diligence work doesn&#8217;t scale down with practice size. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/dentalpracticeloanguide.com\/learn\/dental-practice-broker\">Some brokers also charge an upfront fee, often credited against the final commission<\/a>.<\/p>\n<p>Fee structure affects net proceeds in ways the headline percentage doesn&#8217;t fully capture. Brokers who also collect undisclosed referral fees from buyers face a conflict of interest that can steer sellers toward lower-value outcomes. A sell-side-only advisor, whose only client is the selling dentist, removes that conflict entirely. That same conflict of interest is often the first sign something&#8217;s wrong with a broker relationship, which brings up the warning signs worth watching for.<\/p>\n<h2>Warning Signs to Watch For in a Broker Relationship<\/h2>\n<p>Owners evaluating representation should watch for these signals before signing any engagement agreement.<\/p>\n<ul>\n<li>\n<p><strong>Rushing to contract without a thorough valuation.<\/strong> A broker who skips diligence-grade EBITDA analysis to get a listing signed is prioritizing their own pipeline over the seller&#8217;s outcome.<\/p>\n<\/li>\n<li>\n<p><strong>Inflated or unsupported valuations.<\/strong> Brokers who tell sellers a practice is worth more than buyer due diligence will support can cause deals to collapse, leaving sellers disappointed.<\/p>\n<\/li>\n<li>\n<p><strong>Undisclosed buyer relationships or dual representation.<\/strong> Any arrangement where the broker gets paid by the buyer, disclosed or not, can suppress the seller&#8217;s final proceeds.<\/p>\n<\/li>\n<li>\n<p><strong>Limited DSO or buyer-pool access.<\/strong> A broker who knows only one or two DSOs cannot generate the competitive tension that tends to push valuations higher. Ask how many qualified buyers will actually receive the marketing package.<\/p>\n<\/li>\n<li>\n<p><strong>No side-by-side path comparison.<\/strong> Owners in the $1.5-3 million revenue range can often choose between a private buyer or a DSO. A broker who works only one pathway cannot offer a genuine comparison.<\/p>\n<\/li>\n<li>\n<p><strong>Weak quality-of-earnings defense.<\/strong> A sell-side quality-of-earnings analysis done before marketing can help prevent the 5-15% purchase price reductions that commonly occur when issues surface during buyer due diligence. Brokers who skip this step leave sellers exposed to re-trading at closing.<\/p>\n<\/li>\n<li>\n<p><strong>No blacklist of problematic buyers.<\/strong> Not every DSO makes a good partner. An advisor who sends the practice to every buyer indiscriminately, including undercapitalized or poorly run organizations, puts the seller&#8217;s retained equity and post-close experience at risk.<\/p>\n<\/li>\n<\/ul>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Talk through these red flags with McLerran &amp; Associates<\/strong><\/a> before signing any engagement agreement.<\/p>\n<h2>Weighing the Broker&#8217;s Fee Against What You Gain<\/h2>\n<p>The net-proceeds comparison between represented and unrepresented sellers consistently favors professional representation. Unrepresented sellers often lose value through limited buyer exposure alone, and that loss can exceed the broker&#8217;s success fee by a wide margin.<\/p>\n<p><a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/marketed-process-premium\">Running a competitive auction-style process with a dental-fluent advisor can add roughly 30% to headline price versus selling independently<\/a>. The gap can be even wider with unsolicited offers: <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/marketed-process-premium\">DSOs&#8217; unsolicited offers reportedly underprice practices by up to 50% compared with a competitive marketed process<\/a>.<\/p>\n<p>The valuation defense function matters just as much. Depending on the practice&#8217;s valuation multiple, clean and well-documented add-backs can translate into a meaningfully higher final sale price. A broker whose valuation work cannot survive buyer scrutiny effectively gives that value back during diligence. <a target=\"_blank\" rel=\"noindex nofollow\" href=\"https:\/\/privatepracticeresearch.org\/reports\/marketed-process-premium\">The 6-10% broker fee for a marketed dental practice sale is typically covered several times over by the resulting valuation premium, when the practice has fundamentals that attract multiple qualified bidders<\/a>.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<h2>Questions to Ask Before Hiring a Broker<\/h2>\n<p>These questions can be put to any broker under consideration. The answers reveal whether the advisor is genuinely equipped to represent a premier practice, or is primarily running a listing service.<\/p>\n<ul>\n<li>\n<p><strong>Are you sell-side only?<\/strong> Confirm the firm never represents buyers and receives no compensation from the buyer side.<\/p>\n<\/li>\n<li>\n<p><strong>Who performs the EBITDA analysis, and what credentials do they hold?<\/strong> CPA-led, diligence-grade normalization, including documented add-backs for owner compensation, personal expenses, and non-recurring items, is the standard that holds up under buyer scrutiny.<\/p>\n<\/li>\n<li>\n<p><strong>How many qualified buyers will receive the marketing package, and how do you vet them?<\/strong> Ask specifically about DSO vetting, blacklisted buyers, and how financial qualification gets confirmed before a buyer enters the data room.<\/p>\n<\/li>\n<li>\n<p><strong>What is your documented transaction rate, and how is it calculated?<\/strong> A rigorous process can produce a rate near 85-90%; less structured approaches tend to land closer to the 35-40% industry norm.<\/p>\n<\/li>\n<li>\n<p><strong>Can you model both a doctor-to-doctor and a DSO outcome side by side?<\/strong> Owners in the crossroads revenue range benefit most from a true comparison across both pathways, including multi-year cash-flow modeling that accounts for equity, earnouts, and tax treatment.<\/p>\n<\/li>\n<li>\n<p><strong>How do you defend the valuation through diligence if a buyer attempts to re-trade?<\/strong> Ask for specifics on the quality-of-earnings defense process and how the firm keeps competitive tension alive after an LOI (letter of intent, the preliminary agreement that precedes a final contract) is signed.<\/p>\n<\/li>\n<li>\n<p><strong>What is your fee structure, and are there any undisclosed arrangements with buyers?<\/strong> Full transparency on compensation is a baseline requirement for a sell-side-only advisor.<\/p>\n<\/li>\n<\/ul>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Put these questions directly to McLerran &amp; Associates<\/strong><\/a>, a team that has guided more than 2,000 practice transitions across both pathways.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>Frequently Asked Questions<\/h2>\n<h3>What is the difference between a dental practice broker and a sell-side M&amp;A advisor?<\/h3>\n<p>A traditional dental practice broker typically lists a practice, finds a buyer, and facilitates the transaction, often with a limited buyer pool and a simpler valuation approach. A sell-side M&amp;A advisor performs diligence-grade EBITDA analysis, runs a structured competitive process among vetted buyers, defends the valuation through due diligence, and models multi-year outcomes across deal structures. For premier practices generating $1 million or more in revenue, this distinction matters. The complexity of the DSO pathway in particular calls for deeper analytical and process capabilities.<\/p>\n<h3>How do I know whether to sell to a private buyer or a DSO?<\/h3>\n<p>The right pathway depends on practice size, profitability, and personal goals. Smaller premier practices in the $1-1.5 million revenue range often fit a doctor-to-doctor sale. Larger practices above $1.5 million may qualify for either pathway. Owners in this crossroads range benefit most from a side-by-side valuation that quantifies worth in both markets, including cash-flow modeling that accounts for equity and earnout components common in DSO deals. McLerran &amp; Associates works both pathways in roughly equal measure, so it can offer a genuine comparison rather than steering owners toward one path.<\/p>\n<h3>What happens if a DSO tries to reduce the agreed price during due diligence?<\/h3>\n<p>Re-trading, where a buyer tries to lower the agreed price after signing an LOI based on issues found in due diligence, is one of the most common ways sellers lose value. The main defense is a diligence-grade EBITDA analysis done before the practice goes to market, so there are no surprises for the buyer to exploit. A second defense is maintaining competitive tension by reminding the buyer that other vetted bidders remain available. An advisor who has done the analytical work upfront, and who controls the competitive process, is positioned to hold the valuation number through closing.<\/p>\n<h3>How long does a dental practice sale typically take?<\/h3>\n<p>Timeline varies by pathway. McLerran &amp; Associates&#8217; DSO bid process typically runs 45-60 days from going to market to receiving around 10 offers, with additional time needed to narrow to finalists, negotiate the LOI, and close. Doctor-to-doctor transactions generally take longer to find and qualify the right buyer, but often involve a shorter post-close work-back period, sometimes just 4-8 weeks, compared with the 3-5 year employment commitment typical in DSO deals. Owners who start formal transition planning well ahead of their target exit date tend to see better outcomes than those who start under time pressure.<\/p>\n<h3>Is now a good time to sell a premier dental practice?<\/h3>\n<p>Demand for premier, well-documented practices with strong EBITDA margins remains active, and valuations for top-tier practices are near historical highs. The market has grown more bifurcated, though. Practices with strong fundamentals, diversified production, healthy hygiene programs, and limited owner dependency, continue to attract competitive offers, while practices with structural weaknesses face more valuation pressure. Timing really depends on the specific practice&#8217;s positioning, the owner&#8217;s goals, and current market conditions in their geography and specialty. A comprehensive valuation is the starting point for any informed timing decision.<\/p>\n<h2>Putting the Framework Into Practice<\/h2>\n<p>The six criteria in this guide, valuation methodology, buyer-pool quality, competitive tension, transaction success rate, fee structure, and post-close support, offer a repeatable framework for evaluating any broker or advisor. Applied consistently, they can help surface advisors most likely to defend a practice&#8217;s EBITDA analysis, create genuine competition among vetted buyers, and protect value through the full transaction.<\/p>\n<p>The transaction-rate advantage and pricing premiums referenced earlier reflect what a dental-only, sell-side-only advisory process with CPA-led EBITDA analysis and a vetted national buyer pool can help deliver for owners of premier practices. With roughly 2,000 completed sales, approximately $2 billion in closed transaction volume, and more than 10,000 practices evaluated, McLerran &amp; Associates&#8217; track record offers a useful benchmark for comparing any representation option.<\/p>\n<p>Owners who sell once deserve an advisor who has handled this process thousands of times.<\/p>\n<p><a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\"><strong>Reach out to McLerran &amp; Associates for a free, confidential discovery call<\/strong><\/a> to discuss your practice, your goals, and what a rigorous sell-side process could mean for your outcome. Call <strong>(512) 900-7989<\/strong>, email <strong>info@dentaltransitions.com<\/strong>, or visit <strong>dentaltransitions.com\/contact-us<\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Not all dental brokers deliver equal results. Learn the 6 criteria dentists use to evaluate brokers \u2014 and why McLerran&#8217;s sell-side process stands out.<\/p>\n","protected":false},"author":1,"featured_media":113,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-114","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=114"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/114\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/113"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}